Bernard-Pierre Legrand is the CEO of Juvaplus, a Swiss company specialized in the design and production of compact wireless motorized devices. Juvaplus quickly imposed itself as an innovative company in the aesthetic medicine market. He is behind the commercialization of the JuvaPen, a ground-breaking tool that optimizes toxin injections for both the practitioner and the patient, while dramatically minimizing side effects. In addition, a precision device for micro fat grafting will be displayed at IMCAS 2016. With over 30 years of experience in the field of miniature motorized medical devices, Bernard-Pierre Legrand won the Credit Suisse Prize for the first powered device for arthroscopic surgery, and licensed his innovative devices to Pfizer, Medtronic and Zimmer. He has graduated from ESCP with Masters in International Business.